Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apoptosis | 23 | 2017 | 1789 | 3.880 |
Why?
|
| Phagocytosis | 6 | 2017 | 169 | 2.010 |
Why?
|
| DNA Breaks | 6 | 2017 | 26 | 2.000 |
Why?
|
| Fluorescent Dyes | 8 | 2017 | 261 | 1.910 |
Why?
|
| DNA Damage | 12 | 2017 | 514 | 1.850 |
Why?
|
| In Situ Nick-End Labeling | 8 | 2017 | 124 | 1.670 |
Why?
|
| DNA | 10 | 2017 | 1598 | 1.650 |
Why?
|
| Staining and Labeling | 8 | 2017 | 187 | 1.500 |
Why?
|
| Phagocytes | 3 | 2017 | 24 | 1.140 |
Why?
|
| Biological Assay | 2 | 2017 | 100 | 1.040 |
Why?
|
| Tissue Fixation | 4 | 2017 | 38 | 1.020 |
Why?
|
| Molecular Probe Techniques | 4 | 2017 | 23 | 1.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2017 | 64 | 1.000 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 328 | 0.970 |
Why?
|
| DNA Probes | 8 | 2014 | 124 | 0.950 |
Why?
|
| Oligonucleotide Probes | 6 | 2014 | 85 | 0.920 |
Why?
|
| Thymus Gland | 6 | 2017 | 101 | 0.900 |
Why?
|
| DNA Topoisomerases | 3 | 2014 | 4 | 0.860 |
Why?
|
| Endodeoxyribonucleases | 4 | 2017 | 47 | 0.820 |
Why?
|
| DNA Fragmentation | 5 | 2002 | 54 | 0.760 |
Why?
|
| Polymerase Chain Reaction | 3 | 2017 | 1584 | 0.730 |
Why?
|
| Nanotechnology | 2 | 2014 | 49 | 0.710 |
Why?
|
| Cell Death | 3 | 2017 | 240 | 0.670 |
Why?
|
| Formaldehyde | 2 | 2017 | 34 | 0.630 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2014 | 20 | 0.550 |
Why?
|
| Extracellular Vesicles | 1 | 2017 | 46 | 0.520 |
Why?
|
| Lysosomes | 1 | 2017 | 236 | 0.480 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2014 | 133 | 0.440 |
Why?
|
| Rats | 12 | 2017 | 3687 | 0.430 |
Why?
|
| Cell Nucleus | 2 | 2014 | 677 | 0.410 |
Why?
|
| Caspases | 2 | 2003 | 162 | 0.390 |
Why?
|
| Genetic Techniques | 2 | 2011 | 106 | 0.370 |
Why?
|
| Polyethyleneimine | 2 | 2014 | 10 | 0.370 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2011 | 79 | 0.350 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 391 | 0.350 |
Why?
|
| Adrenal Cortex | 3 | 1999 | 10 | 0.330 |
Why?
|
| Protein Transport | 2 | 2014 | 368 | 0.330 |
Why?
|
| Cyclins | 3 | 1999 | 101 | 0.320 |
Why?
|
| Vaccinia virus | 3 | 2014 | 52 | 0.320 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2006 | 395 | 0.310 |
Why?
|
| Molecular Probes | 2 | 2006 | 30 | 0.310 |
Why?
|
| DNA Ligases | 2 | 2012 | 16 | 0.290 |
Why?
|
| Biomarkers | 1 | 2017 | 2980 | 0.290 |
Why?
|
| Animals | 22 | 2017 | 34139 | 0.280 |
Why?
|
| In Situ Hybridization | 2 | 2006 | 470 | 0.280 |
Why?
|
| Reperfusion Injury | 2 | 1999 | 103 | 0.280 |
Why?
|
| Brain Ischemia | 2 | 2014 | 258 | 0.270 |
Why?
|
| Horseradish Peroxidase | 1 | 2006 | 14 | 0.260 |
Why?
|
| Macrophages | 3 | 2017 | 617 | 0.260 |
Why?
|
| Cell Membrane | 2 | 2005 | 459 | 0.260 |
Why?
|
| Nanotubes | 1 | 2006 | 13 | 0.260 |
Why?
|
| Stroke | 1 | 2014 | 974 | 0.260 |
Why?
|
| Quantum Dots | 1 | 2006 | 12 | 0.260 |
Why?
|
| Povidone | 1 | 2005 | 5 | 0.250 |
Why?
|
| Nanotubes, Carbon | 1 | 2005 | 19 | 0.250 |
Why?
|
| Materials Testing | 1 | 2005 | 73 | 0.250 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2002 | 87 | 0.240 |
Why?
|
| Nucleic Acid Conformation | 3 | 2002 | 184 | 0.230 |
Why?
|
| Phagosomes | 2 | 2017 | 35 | 0.230 |
Why?
|
| Necrosis | 3 | 2003 | 206 | 0.230 |
Why?
|
| Thimerosal | 1 | 2003 | 3 | 0.220 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2003 | 14 | 0.210 |
Why?
|
| Transfection | 1 | 2005 | 1069 | 0.210 |
Why?
|
| DNA, Single-Stranded | 2 | 1993 | 75 | 0.210 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 59 | 0.210 |
Why?
|
| 3' Untranslated Regions | 1 | 2003 | 165 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2005 | 889 | 0.200 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 301 | 0.200 |
Why?
|
| Glioblastoma | 2 | 2005 | 334 | 0.200 |
Why?
|
| Cells, Cultured | 5 | 2017 | 3050 | 0.190 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2002 | 80 | 0.180 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 1684 | 0.170 |
Why?
|
| Ligases | 1 | 1999 | 46 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 578 | 0.160 |
Why?
|
| Fluorescence | 2 | 2014 | 94 | 0.160 |
Why?
|
| Biotin | 2 | 1998 | 45 | 0.150 |
Why?
|
| Chromosome Breakage | 1 | 1998 | 168 | 0.140 |
Why?
|
| Molecular Biology | 1 | 1998 | 77 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 3 | 2005 | 1064 | 0.140 |
Why?
|
| Humans | 19 | 2017 | 124394 | 0.140 |
Why?
|
| Cell Survival | 2 | 2014 | 806 | 0.140 |
Why?
|
| Cathepsin D | 1 | 2017 | 16 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 31 | 0.140 |
Why?
|
| Digoxigenin | 1 | 1996 | 2 | 0.130 |
Why?
|
| Adamantane | 1 | 1996 | 6 | 0.130 |
Why?
|
| Exosomes | 1 | 2017 | 43 | 0.130 |
Why?
|
| Neurons | 2 | 2003 | 1964 | 0.130 |
Why?
|
| Proteolysis | 1 | 2017 | 169 | 0.130 |
Why?
|
| Histocytochemistry | 1 | 2014 | 99 | 0.110 |
Why?
|
| Anions | 1 | 2014 | 18 | 0.110 |
Why?
|
| Cations | 1 | 2014 | 39 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 426 | 0.110 |
Why?
|
| Membranes, Artificial | 1 | 1993 | 27 | 0.110 |
Why?
|
| Nylons | 1 | 1993 | 12 | 0.110 |
Why?
|
| Polyethylenes | 1 | 1993 | 8 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1697 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 1244 | 0.100 |
Why?
|
| Caspase 3 | 2 | 2003 | 134 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2014 | 348 | 0.100 |
Why?
|
| Vaccinia | 1 | 2012 | 8 | 0.100 |
Why?
|
| Energy Transfer | 2 | 2002 | 16 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1999 | 1228 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 719 | 0.090 |
Why?
|
| DNA Polymerase I | 1 | 2011 | 10 | 0.090 |
Why?
|
| Frozen Sections | 1 | 2011 | 25 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 33 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 1999 | 82 | 0.080 |
Why?
|
| Cell Line | 1 | 2014 | 2770 | 0.080 |
Why?
|
| Dexamethasone | 2 | 2002 | 276 | 0.080 |
Why?
|
| Male | 10 | 2017 | 61025 | 0.080 |
Why?
|
| Lymphoma | 1 | 2011 | 322 | 0.070 |
Why?
|
| Base Sequence | 3 | 2002 | 3093 | 0.070 |
Why?
|
| Cattle | 3 | 1996 | 563 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3341 | 0.070 |
Why?
|
| Enzymes, Immobilized | 1 | 2006 | 6 | 0.070 |
Why?
|
| Wilms Tumor | 2 | 1998 | 113 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 42 | 0.060 |
Why?
|
| Avidin | 1 | 2005 | 18 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 45 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2005 | 10 | 0.060 |
Why?
|
| Optical Devices | 1 | 2005 | 3 | 0.060 |
Why?
|
| Hydrazines | 1 | 2005 | 29 | 0.060 |
Why?
|
| Particle Size | 1 | 2005 | 121 | 0.060 |
Why?
|
| Polymers | 1 | 2005 | 108 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 4355 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4534 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2005 | 166 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 31 | 0.050 |
Why?
|
| Deoxyribonucleotides | 1 | 2003 | 10 | 0.050 |
Why?
|
| Freezing | 1 | 2003 | 28 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 77 | 0.050 |
Why?
|
| Dihydroorotase | 1 | 2002 | 6 | 0.050 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2002 | 6 | 0.050 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2002 | 6 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 22 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2002 | 26 | 0.050 |
Why?
|
| Brain | 1 | 2014 | 3003 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2002 | 29 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2002 | 102 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 33 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 90 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 69 | 0.050 |
Why?
|
| Cardiac Output, Low | 2 | 2000 | 67 | 0.050 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 107 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2001 | 53 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 172 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2005 | 8184 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 348 | 0.040 |
Why?
|
| Skin | 1 | 2003 | 510 | 0.040 |
Why?
|
| Biotinylation | 1 | 1999 | 22 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 455 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1999 | 21 | 0.040 |
Why?
|
| Cyclin E | 1 | 1999 | 30 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 447 | 0.040 |
Why?
|
| Mice | 3 | 2014 | 17725 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 412 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 259 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1687 | 0.040 |
Why?
|
| Time Factors | 2 | 2002 | 6272 | 0.040 |
Why?
|
| Complement C1q | 1 | 1999 | 19 | 0.040 |
Why?
|
| Complement Activation | 1 | 1999 | 52 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1999 | 124 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 549 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1999 | 246 | 0.040 |
Why?
|
| Autolysis | 1 | 1996 | 1 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1996 | 43 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 467 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1999 | 418 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1996 | 4 | 0.030 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 1996 | 8 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1996 | 136 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 1996 | 57 | 0.030 |
Why?
|
| Tissue Donors | 1 | 1999 | 486 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1996 | 98 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2000 | 338 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 68 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 395 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 645 | 0.030 |
Why?
|
| Motor Activity | 1 | 1999 | 525 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1996 | 213 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 672 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1998 | 360 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2030 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 969 | 0.030 |
Why?
|
| Gene Expression | 2 | 1996 | 1569 | 0.030 |
Why?
|
| Filtration | 1 | 1993 | 23 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1993 | 97 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1993 | 105 | 0.030 |
Why?
|
| Ultrasonography | 1 | 1998 | 928 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1993 | 313 | 0.030 |
Why?
|
| Melanoma | 1 | 1999 | 832 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 1996 | 2824 | 0.030 |
Why?
|
| Child, Preschool | 2 | 1998 | 14085 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1996 | 813 | 0.020 |
Why?
|
| Kidney | 1 | 1998 | 1345 | 0.020 |
Why?
|
| Mutation | 1 | 2001 | 5808 | 0.020 |
Why?
|
| Child | 2 | 1999 | 24526 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2000 | 844 | 0.010 |
Why?
|
| Disease Progression | 2 | 2000 | 2042 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 2699 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 3873 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2000 | 54 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 311 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2000 | 107 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1999 | 49 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 59 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 386 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1999 | 112 | 0.010 |
Why?
|
| Cell Communication | 1 | 2000 | 167 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1999 | 86 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1998 | 40 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 144 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 657 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 274 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 892 | 0.010 |
Why?
|
| Middle Aged | 1 | 1996 | 26459 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 665 | 0.010 |
Why?
|
| RNA | 1 | 1999 | 568 | 0.010 |
Why?
|
| Echocardiography | 1 | 2000 | 1052 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1995 | 153 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 1995 | 161 | 0.010 |
Why?
|
| Heart | 1 | 1998 | 718 | 0.010 |
Why?
|
| Female | 1 | 1998 | 66301 | 0.000 |
Why?
|